[1] |
付玉姣, 郭静, 史娜娜, 等. 抗γ干扰素自身抗体阳性伴Sweet综合征的马尔尼菲篮状菌病九例临床分析[J]. 中华皮肤科杂志, 2020,53(2): 109⁃112. doi: 10.35541/cjd.20190746.
|
[2] |
Nofal A, Abdelmaksoud A, Amer H, et al. Sweet′s syndrome: diagnostic criteria revisited[J]. J Dtsch Dermatol Ges, 2017,15(11):1081⁃1088. doi: 10.1111/ddg.13350.
|
[3] |
Chaowattanapanit S, Choonhakarn C, Chetchotisakd P, et al. Clinical features and outcomes of Sweet′s syndrome associated with non⁃tuberculous mycobacterial infection and other associated diseases[J]. J Dermatol, 2016,43(5):532⁃536. doi: 10.1111/1346⁃8138.13167.
|
[4] |
Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult⁃onset immunodeficiency in Thailand and Taiwan[J]. N Engl J Med, 2012,367(8):725⁃734. doi: 10.1056/NEJMoa1111160.
|
[5] |
Dorman SE, Holland SM. Interferon⁃gamma and interleukin⁃12 pathway defects and human disease[J]. Cytokine Growth Factor Rev, 2000,11(4):321⁃333. doi: 10.1016/s1359⁃6101(00)00010⁃1.
|
[6] |
Jutivorakool K, Sittiwattanawong P, Kantikosum K, et al. Skin manifestations in patients with adult⁃onset immunodeficiency due to anti⁃interferon⁃gamma autoantibody: a relationship with systemic infections[J]. Acta Derm Venereol, 2018,98(8):742⁃747. doi: 10.2340/00015555⁃2959.
|
[7] |
Kampitak T, Suwanpimolkul G, Browne S, et al. Anti⁃interferon⁃γ autoantibody and opportunistic infections: case series and review of the literature[J]. Infection, 2011,39(1):65⁃71. doi: 10.1007/s15010⁃010⁃0067⁃3.
|
[8] |
Xu H, Liu D, He X, et al. Sweet′s syndrome associated with Talaromyces marneffei and Mycobacterium abscessus infection due to anti⁃interferon⁃gamma autoantibodies[J]. Indian J Dermatol, 2018,63(5):428⁃430. doi: 10.4103/ijd.IJD_362_17.
|